0001562180-20-007466.txt : 20201228
0001562180-20-007466.hdr.sgml : 20201228
20201228160239
ACCESSION NUMBER: 0001562180-20-007466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201221
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSMITH MARK A
CENTRAL INDEX KEY: 0001246842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 201418413
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-12-21
false
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0001246842
GOLDSMITH MARK A
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200
CAMBRIDGE
MA
02142
true
false
true
false
Common Stock
2020-12-21
4
S
false
4020.00
35.0172
D
139043.00
I
Owned by Trusts for which Mark A. Goldsmith is a Trustee
These trades were made pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $35.00 to $35.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Emma Reeve, as Attorney-in-Fact for Mark A. Goldsmith
2020-12-28